{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:31:16Z","timestamp":1793241076630,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109630","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:37:10Z","timestamp":1770943030000},"page":"109630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development of coumarin-based acetylcholinesterase inhibitors: Synthesis, biological assessment and computational simulations"],"prefix":"10.1016","volume":"173","author":[{"given":"Nouran E.","family":"Emam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana H.","family":"Refaey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.","family":"El-Ashrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa R.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassin M.","family":"Nissan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad M.","family":"Seif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109630_bb0005","series-title":"2025 Alzheimer's disease facts and figures, Alzheimer's Dement","first-page":"1","volume":"21","year":"2025"},{"key":"10.1016\/j.bioorg.2026.109630_bb0010","doi-asserted-by":"crossref","DOI":"10.47611\/jsrhs.v10i2.1524","article-title":"The Media's influence on the validity of medical information regarding Alzheimer's Disease","volume":"10","author":"Korukonda","year":"2021","journal-title":"J. Student Res."},{"key":"10.1016\/j.bioorg.2026.109630_bb0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jalz.2018.10.003","article-title":"Subjective cognitive decline and rates of incident Alzheimer's disease and non\u2013Alzheimer's disease dementia","volume":"15","author":"Slot","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bioorg.2026.109630_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Bu\u00e9e","year":"2000","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bioorg.2026.109630_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116065","article-title":"Targeting glycogen synthase kinase-3\u03b2 for Alzheimer's disease: recent advances and future prospects","volume":"265","author":"Cheng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109630_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00391-7","article-title":"Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease","volume":"15","author":"Guo","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bioorg.2026.109630_bb0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bioorg.2026.109630_bb0040","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer's Disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J. Alzheimer's Dis"},{"key":"10.1016\/j.bioorg.2026.109630_bb0045","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jalz.2015.05.007","article-title":"Introduction to special issue: overview of Alzheimer's Disease Neuroimaging Initiative","volume":"11","author":"Weiner","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bioorg.2026.109630_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2015.06.1883","article-title":"Alzheimer's Disease Neuroimaging Initiative: a decade of progress in Alzheimer's disease","volume":"11","author":"Thies","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bioorg.2026.109630_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2022.10.004","article-title":"An update on the novel and approved drugs for Alzheimer disease","volume":"30","author":"Alhazmi","year":"2022","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bioorg.2026.109630_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112556","article-title":"The biological activities of butyrylcholinesterase inhibitors","volume":"146","author":"Zhou","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.109630_bb0065","article-title":"Novel small molecule-based acetylcholinesterase (AChE) inhibitors: from biological perspective to recent developments","volume":"12","author":"Sobha","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.bioorg.2026.109630_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-021-00838-z","article-title":"Aducanumab produced a clinically meaningful benefit in association with amyloid lowering","volume":"13","author":"Cummings","year":"2021","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.bioorg.2026.109630_bb0075","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.bioorg.2026.109630_bb0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in Alzheimer's disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.bioorg.2026.109630_bb0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0009-2797(93)90042-W","article-title":"Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs","volume":"87","author":"Sussman","year":"1993","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2026.109630_bb0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2010.01.042","article-title":"Acetylcholinesterase: from 3D structure to function","volume":"187","author":"Dvir","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2026.109630_bb0095","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/cns.13035","article-title":"A review of clinical treatment considerations of donepezil in severe Alzheimer's disease","volume":"24","author":"Adlimoghaddam","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bioorg.2026.109630_bb0100","doi-asserted-by":"crossref","unstructured":"J.S. Birks, R.J. Harvey, Donepezil for dementia due to Alzheimer's disease, Cochrane Database Syst. Rev. 6 (2018) CD001190. doi:https:\/\/doi.org\/10.1002\/14651858.CD001190.pub3.","DOI":"10.1002\/14651858.CD001190.pub3"},{"key":"10.1016\/j.bioorg.2026.109630_bb0105","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1021\/acs.jcim.9b01073","article-title":"Donepezil inhibits acetylcholinesterase via multiple binding modes at room temperature","volume":"60","author":"Silva","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.109630_bb0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1527-3458.2001.tb00204.x","article-title":"Donepezil for Alzheimer's disease: pharmacodynamic, pharmacokinetic, and clinical profiles","volume":"7","author":"Shigeta","year":"2001","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.bioorg.2026.109630_bb0115","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s11030-019-09992-x","article-title":"Coumarins: antifungal effectiveness and future therapeutic scope","volume":"24","author":"Prusty","year":"2020","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.109630_bb0120","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/jcpt.13644","article-title":"Synthetic and natural coumarins as potent anticonvulsant agents: a review with structure-activity relationship","volume":"47","author":"Keri","year":"2022","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.bioorg.2026.109630_bb0125","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.2174\/1389557521666210405160323","article-title":"Anticancer potential of coumarin and its derivatives","volume":"21","author":"Bhattarai","year":"2021","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109630_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900380","article-title":"Coumarin-containing hybrids and their antibacterial activities","volume":"353","author":"Feng","year":"2020","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.bioorg.2026.109630_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174867","article-title":"Coumarins derivatives and inflammation: review of their effects on the inflammatory signaling pathways","volume":"922","author":"Rostom","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109630_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104792","article-title":"Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease","volume":"110","author":"Amin","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109630_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbi.2016.05.001","article-title":"Coumarins as cholinesterase inhibitors: a review","volume":"254","author":"de Souza","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2026.109630_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01552","article-title":"Coumarin derivatives as acetyl- and butyrylcholinestrase inhibitors: an in vitro, molecular docking, and molecular dynamics simulations study","volume":"5","author":"Abu-Aisheh","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.bioorg.2026.109630_bb0155","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1016\/j.bmc.2014.06.057","article-title":"Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, A\u03b2 aggregation, and \u03b2-secretase","volume":"22","author":"Sun","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109630_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131591","article-title":"New coumarin-pyrazole hybrids: synthesis, docking studies and biological evaluation as potential cholinesterase inhibitors","volume":"1249","author":"Benazzouz-Touami","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109630_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131085","article-title":"Novel series of triazole containing coumarin and isatin based hybrid molecules as acetylcholinesterase inhibitors","volume":"1245","author":"Bhagat","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109630_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129784","article-title":"Design, synthesis and biological evaluation of new carbazole-coumarin hybrids as dual binding site inhibitors of acetylcholinesterase","volume":"1229","author":"Song","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109630_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29153514","article-title":"Naturally inspired coumarin derivatives in Alzheimer's disease drug discovery: latest advances and current challenges","volume":"29","author":"Orioli","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109630_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111651","article-title":"Neurobehavioral investigation and acetylcholinesterase inhibitory activity study for some new coumarin derivatives","volume":"182","author":"Mahmoud","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109630_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-022-00885-z","article-title":"Synthesis and bioactivities evaluation of quinazolin-4(3H)-one derivatives as \u03b1-glucosidase inhibitors","volume":"16","author":"Moheb","year":"2022","journal-title":"BMC Chem."},{"key":"10.1016\/j.bioorg.2026.109630_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114152","article-title":"Synthesis, biological evaluation, and molecular modeling simulations of new heterocyclic hybrids as multi-targeted anti-Alzheimer's agents","volume":"231","author":"Waly","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109630_bb0195","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10895-015-1741-8","article-title":"Synthesis and fluorescence properties of Eu3+, Tb3+ complexes with Schiff base derivatives","volume":"26","author":"Liu","year":"2016","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.bioorg.2026.109630_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135721","article-title":"Facile one-pot, three-component synthesis and antimicrobial screening of novel hexahydropyrimido[4,5-b]quinolinediones incorporating phenoxylacetamide core as novel hybrid molecules via Hantzsch reaction","volume":"1287","author":"Diab","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109630_bb0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.apjtm.2016.01.014","article-title":"Anti-Alzheimer's disease potential of coumarins from Angelica decursiva and Artemisia capillaris and structure-activity analysis","volume":"9","author":"Ali","year":"2016","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.bioorg.2026.109630_bb0210","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1358\/mf.2000.22.8.701373","article-title":"Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro","volume":"22","author":"Ogura","year":"2000","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109630_bb0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00002093-200304000-00011","article-title":"Inhibition of human cholinesterases by drugs used to treat Alzheimer disease","volume":"17","author":"Darvesh","year":"2003","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.bioorg.2026.109630_bb0220","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.18632\/oncotarget.2037","article-title":"GSK-3 as potential target for therapeutic intervention in cancer","volume":"5","author":"McCubrey","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.109630_bb0225","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.6026\/97320630091023","article-title":"The role of CDK5 and GSK3B kinases in hyperphosphorylation of microtubule associated protein tau (MAPT) in Alzheimer's disease","volume":"9","author":"Jayapalan","year":"2013","journal-title":"Bioinformation"},{"key":"10.1016\/j.bioorg.2026.109630_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060797","article-title":"Nigella and milk thistle seed oils: potential cytoprotective effects against 7\u03b2-hydroxycholesterol-induced toxicity on sh-sy5y cells","volume":"11","author":"Hammouda","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.109630_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.103009","article-title":"Metal ion mediated aggregation of Alzheimer's disease peptides and proteins in solutions and at surfaces","volume":"320","author":"Feng","year":"2023","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.bioorg.2026.109630_bb0240","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035142","article-title":"Research progress of ferroptosis in Alzheimer disease: a review","volume":"102","author":"Han","year":"2023","journal-title":"Med. (Baltimore)"},{"key":"10.1016\/j.bioorg.2026.109630_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109630_bb0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2026.109630_bb0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1998","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.bioorg.2026.109630_bb0260","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109630_bb0265","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109630_bb0270","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109630_bb0275","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.109630_bb0280","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.poly.2010.12.037","article-title":"Synthesis, structure, spectroscopic properties, electrochemistry, and DFT correlative studies of N-[(2-pyridyl)methyliden]-6-coumarin complexes of Cu(I) and Ag(I)","volume":"30","author":"Roy","year":"2011","journal-title":"Polyhedron"},{"key":"10.1016\/j.bioorg.2026.109630_bb0285","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/00397911.2019.1692225","article-title":"Synthesis of N-aryl 2-chloroacetamides and their chemical reactivity towards various types of nucleophiles","volume":"50","author":"Abdel-Latif","year":"2020","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2026.109630_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2014.04.030","article-title":"Synthesis, cytotoxic study and docking based multidrug resistance modulator potential analysis of 2-(9-oxoacridin-10(9H)-yl)-N-phenyl acetamides","volume":"80","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109630_bb0295","first-page":"137","article-title":"Synthesis and cytotoxic evaluation of some 2-{4-[(2-oxo-1,2-dihydro-3h-indol-3-ylidene)methyl] phenoxy}-n-phenylacetamide","volume":"74","author":"Bhadauria","year":"2017","journal-title":"Acta Pol. Pharm. Drug Res."},{"key":"10.1016\/j.bioorg.2026.109630_bb0300","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109630_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26051198","article-title":"New adenosine derivatives from Aizoon canariense L.: in vitro anticholinesterase, antimicrobial, and cytotoxic evaluation of its extracts","volume":"26","author":"Bakr","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109630_bb0310","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molstruc.2019.06.071","article-title":"New cyclooctathienopyridine derivatives in the aim of discovering better Anti-Alzheimer's agents","volume":"1196","author":"El-Malah","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109630_bb0315","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33354-6","article-title":"Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay","volume":"8","author":"Jang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109630_bb0320","series-title":"GROMACS 2022.4 Manual","author":"Bauer","year":"2022"},{"key":"10.1016\/j.bioorg.2026.109630_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple amber force fields and development of improved protein backbone parameters","volume":"65","author":"Hornak","year":"2006","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"10.1016\/j.bioorg.2026.109630_bb0330","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-5-367","article-title":"ACPYPE - antechamber python parser interface","volume":"5","author":"Sousa Da Silva","year":"2012","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.bioorg.2026.109630_bb0335","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioorg.2026.109630_bb0340","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1021\/ct9001015","article-title":"Staggered mesh Ewald: an extension of the smooth particle-mesh Ewald method adding great versatility","volume":"5","author":"Cerutti","year":"2009","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2026.109630_bb0345","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/ct700200b","article-title":"P-LINCS: a parallel linear constraint solver for molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2026.109630_bb0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:55:41Z","timestamp":1772891741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826001665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":70,"alternative-id":["S0045206826001665"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109630","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of coumarin-based acetylcholinesterase inhibitors: Synthesis, biological assessment and computational simulations","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109630"}}